I know I said I would stop writing about 23andSerge. I will, but I am still going to write about what I think may go down next week in D.C. Land.
As you may know, I am a big supporter of classifying DTCG tests in certain ways
1. If the company has purported some sort of health benefits or decisions regarding medical care for a test, then it should be classified as a medical device and regulated as such. Class II or Class III
2. If a DTCG test does actually have medical implications for treatment, diagnosis or prevention, regardless of what a company says, this should be a Class III subject to premarket review.
3. If a DTCG test has nothing in the way of health implications or diagnosis, treatment or prevention it should not be considered medical.
If 3 should become item one or 2 based on new evidence, then it should be regulated as item one or 2.
What do I think should happen here with the FDA and DTCG? Well, it depends.
One has to ask first, will regulation stifle innovation?
If you ask me, most of this rhetoric is merely legal polemic. I have seen very scant evidence on the horrible effect it has on health or longevity.
In fact most of the “evidence” on regulation seem to come and angry blog posts and twitter feeds.
But to get at the heart of this issue facing regulators we need to ask a follow up. Is innovation a good thing?
A priori I would say yes. Always? No.
I challenge anyone to prove to me that some innovation hasn’t led to bad things or bad outcomes. “Magic Mineral” anyone?
Assuming that not all innovation is good, we can see the role of regulation to prevent the harm of bad innovation. Is that such a bad thing?. A poll in May finds that 72% of Americans trust the job the FDA does. They also are wayin favor of regulation of innovation in the space.
Now the FDA needs a litmus test for genomic innovation to define their regulation. What defines bad innovation?
I would say:
1. Potential for human harm from use of innovation.
2. Misrepresentations of expected outcomes from using innovation.
3. Lack of innovation performance of stated use.
I think in some ways, certain DTCG companies
Number One is a potential in some peoples minds, but I have clinical examples that were presented by K.O. a year or 2 ago.
Unfortunately for the FDA, they have some lines and categories already which can create some rigidity in their guidance. And may not apply the scale I use.
But, it is just a construct. Similar to the one I presented before.
Will the FDA throw out traditional guidance here?
They will follow the construct listed here, no matter how many people rant and rave at the DC meeting. Why?
I just told you. The public wants innovation in healthcare regulated. Which leads me to my next question. What do you think congress will do?
The Sherpa Says: We have to stop ranting about how the world will end if this tiny little field with the “unproven” ability to transform medicine sans clinician has to face regulatory scrutiny. Instead, we have to ask, is this a good innovation now? How will we make it a good innovation? Can we?
(2) Very similar to how the Pharma companies complain about regulation.
(3) via law school papers
(4) Or how about derivatives trading?
(5) The general pubic doesn’t think so
(6) have had 2 and 3.
- OMICS Group Incorporation Acquires Journal of Molecular and Genetic Medicine from LibPubMedia - June 15th, 2013
- Genetic medicine unit now seeing 800 new cases a year in bid to prevent inherited cancers - May 16th, 2013
- Simple and inexpensive method to cut DNA could transform genetic medicine - January 10th, 2013
- Concepts In Genetic Medicine - Video - December 28th, 2012
- Immune System Changes May Drive Aggressiveness of Recurrent Tumors - December 28th, 2012
- Genetic Variations Cause Diabetes - December 26th, 2012
- Autism Cures Promised by DNA Testers Belied by Regulators - December 25th, 2012
- Concepts in Genetic - Video - December 24th, 2012
- Hundreds Of Genetic Mutations Linked To Autism - December 24th, 2012
- New Findings in the Search for Genetic Clues to Insulin Production - December 24th, 2012
- Three new genetic links to colorectal cancer - December 24th, 2012
- 3 new genetic links to colorectal cancer - December 24th, 2012
- Genetic clues to insulin production: Genomic analysis method helps track genetic contributors relevant to diabetes - December 24th, 2012
- Canadians answer call to share genetic data - December 22nd, 2012
- Major source of evolutionary differences among species uncovered - December 22nd, 2012
- Rogers Textbook of - Video - December 21st, 2012
- DNA Disruptors: Our Genetic Future (Pt. 3) - December 21st, 2012
- DNA Disruptors: Our Genetic Future (Pt. 2) - December 21st, 2012
- Genetic Mutations Lead To Autism And Other Disorders - December 21st, 2012
- DNA Disruptors: Our Genetic Future (Pt. 1) - December 21st, 2012
- Researchers reveal genetic basis for fundamental differences between humans and other vertebrates - December 21st, 2012
- Genetic action shows results on childhood brain disease Canavan - December 21st, 2012
- Genetic defect causing fragile X-related disorders more common than thought - December 21st, 2012
- Researchers Track The Origins Of HIV Through Genetic Variants - December 20th, 2012
- Study Finds Genetic Variation That Could Help Predict Mortality in Patients Suffering Sepsis - December 20th, 2012
- Genetic variation that could help predict mortality in patients suffering sepsis identified - December 20th, 2012
- The Promise -- and Perils -- of Personalized Medicine - December 20th, 2012
- Genetic manipulation of urate alters neurodegeneration in mouse model of Parkinson's disease - December 18th, 2012
- Move to protect traditional knowledge, genetic resources - December 18th, 2012
- Univ. of MD School of Medicine to study drug-resistant malaria in Myanmar - December 18th, 2012
- Report from the front lines of personalized reproductive medicine revolution - December 16th, 2012
- Two new genetic mutations associated with Cowden syndrome identified - December 14th, 2012
- Cleveland Clinic researcher identifies 2 new genetic mutations associated with Cowden syndrome - December 14th, 2012
- Home genetic test to dip to $99 - December 13th, 2012
- World's First "Hearts and Minds" Clinic for Adults with Genetic Syndrome - December 12th, 2012
- The £100 genetic map means everybody's DNA make-up could be available in 'very near future' - December 12th, 2012
- Genetic knowledge helps tailor treatment - December 12th, 2012
- Everybody's DNA could be on genetic map in 'very near future' - December 10th, 2012
- Genetic Fingerprint in Your Belly? - December 10th, 2012
- Hershey Medical Center's personalized medicine 'will do people in the community a lot of good,' expert says - December 9th, 2012
- Dispatch Special Report | Unlocking genetic secrets - December 9th, 2012
- Nobody Is Perfect: Study Shows People Have 400 Genetic Flaws In DNA - December 8th, 2012
- New Genetic Testing Reveals More Prenatal Abnormalities - December 8th, 2012
- Unlocking the genetic mysteries behind stillbirth - December 6th, 2012
- New prenatal genetic test gives parents more answers - December 6th, 2012
- A New Genetic Fingerprint Lives in Your Gut - December 6th, 2012
- Advanced Genetic Tests Spot More Defects Before Birth - December 6th, 2012
- Cancer, Genetic Risks and Precision Medicine Highlighted at Showcase - December 6th, 2012
- Genetic Test Reveals More About Potential Birth Defects Than Conventional Methods - December 6th, 2012
- Inflammation may be a cause of plaque buildup in heart vessels - December 5th, 2012
- International study points to inflammation as a cause of plaque buildup in heart vessels - December 5th, 2012
- Genetic variation recent, varies among populations - December 5th, 2012
- New Book on Genome and Personalized Medicine Preps Doctors for Changing Reality - December 5th, 2012
- Scientists identify 15 new genetic regions associated with coronary artery disease - December 5th, 2012
- Personalized Molecular Medicine Firm Genection Launched - December 5th, 2012
- Partners going personal - December 5th, 2012
- Weill Cornell researchers elected Fellows of AAAS - November 30th, 2012
- My Beautiful Genome: exposing our genetic future, one quirk at a time – review - November 26th, 2012
- New genetic test for fetus can give parents more questions than answers - November 16th, 2012
- 1092 human genomes sequenced to determine standard range of human genetic variation - November 2nd, 2012
- 03: Genetic Medicine (MRes): Bill Newman: why choose this course? - Video - October 30th, 2012
- 05: Genetic Medicine (MRes): Bill Newman: Manchester population genetics - Video - October 30th, 2012
- Genetic Medicine (MRes): Bill Newman: Career prospects - Video - October 30th, 2012
- The Health Quarter - Video - October 30th, 2012
- Hope for Duchenne sufferers - Video - October 30th, 2012
- Dr. David Valle Speaks About Evolutionary Medicine - Video - October 30th, 2012
- Advancing Health Care: Personalized Genetic Medicine - Video - October 30th, 2012
- Implementing of Genetic Medicine Programs: Laboratories - Debra Leonard - Video - October 30th, 2012
- Deadly Medicine Panel Discussion: Meanings and Implications of Nazism and Eugenics - Video - October 30th, 2012
- Cancer Trends Plenary Session (part II) -- Bio-IT World Expo 2012 - Video - October 30th, 2012
- Targeting genetic medicine - Video - October 30th, 2012
- LA Society for the Arts in Healthcare Event - Video - October 30th, 2012
- Yolantha Harrison-Pace: Author, Poet, Playwright - Video - October 30th, 2012
- USC Institute for Genetic Medicine Art Show - Video - October 30th, 2012
- Dolan Lecture Series 2000 - Ronald G. Crystal, MD - Video - October 30th, 2012
- Implementation of Genetic Medicine Programs: Laboratories - Stephen Chanok - Video - October 30th, 2012
- Shane McKee: Showreel 1 - Video - October 30th, 2012
- 3D Printing: The Future of Manufacturing - Video - October 30th, 2012
- Richard Morimoto, 2nd International Conference «Genetics of Aging and Longevity» - Video - October 30th, 2012
- Update on Down Syndrome Research: A Collaboration Between DSRTF and NDSS - Video - October 30th, 2012